Long-term bone health in glucocorticoid-treated children with rheumatic diseases

Current Rheumatology Reports

Volumn 15, Issue 3, 2013, Pages

  Rousseau Nepton, Isabelle ^a   Lang, Bianca ^b   Rodd, Celia ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

BMD; Bone health; Children; DXA; Fragility fractures; Glucocorticoids; Hypovitaminosis D; Long term bone health; Low bone mass; Osteoporosis; Rheumatic diseases; Vertebral fractures; Vitamin D

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIUM; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; VITAMIN D;

ARTICLE; BONE DENSITY; BONE MASS; CHILD; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOREARM FRACTURE; FRACTURE REDUCTION; HEALTH HAZARD; HUMAN; INCIDENCE; LONG BONE; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PREVALENCE; RHEUMATIC DISEASE; SPINE FRACTURE; SPINE RADIOGRAPHY; VITAMIN D DEFICIENCY; WRIST FRACTURE;

EID: 84873366479     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-012-0315-x     Document Type: Article

References (42)

1. Cassidy J, Petty R, Laxer R, et al. Textbook of Pediatric Rheumatology. 6th ed. Saunders; 2011.
2. Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465-82. doi:10.1002/acr.20460.
3. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310-7. doi:10.1136/ard.2008.088096.
4. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68(3):318-23. doi:10.1136/ard.2008.088351.
5. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res. 2012;64(6):797-808. doi:10.1002/acr.21664.
6. Thornton J, Ashcroft D, O'Neill T, et al. A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on longterm risk of fracture and cost of disease management. Health Technology Assessment (Winchester, England). 2008;12(3):iii- ix, xi-xiv, 1-208.
7. Varonos S, Ansell BM, Reeve J. Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy. Calcif Tissue Int. 1987;41(2):75-8.
8. Burnham JM, Shults J, Weinstein R, et al. Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis. 2006;65(8):1074-9. doi:10.1136/ard.2005.048835.
9. Lien G, Flato B, Haugen M, et al. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a longterm outcome study of one hundred five patients. Arthritis Rheum. 2003;48(8):2214-23. doi:10.1002/art. 11097.
10. Canalis E. Effects of tumor necrosis factor on bone formation in vitro. Endocrinology. 1987;121(5):1596-604.
11. Alsufyani KA, Ortiz-Alvarez O, Cabral DA, et al. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol. 2005;32(4):729-33.
12. Stagi S, Masi L, Capannini S, et al. Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients. J Rheumatol. 2010;37(9):1935-43. doi:10.3899/jrheum.091241.
13. Liu WG, He SC, Deng G, et al. Risk factors for new vertebral fractures after percutaneous vertebroplasty in patients with osteoporosis: a prospective study. J Vasc Int Radiol: JVIR. 2012;23 (9):1143-9. doi:10.1016/j.jvir.2012.06. 019.
14. Nakamura T, Sugimoto T, Nakano T, et al. Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1-34] Once- Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk. J Clin Endocrinol Metab. 2012;97(9):3097-106. doi:10.1210/jc.2011-3479.
15. Rho YJ, Choe WJ, Chun YI. Risk factors predicting the new symptomatic vertebral compression fractures after percutaneous vertebroplasty or kyphoplasty. Eur Spine J. 2012;21(5):905-11. doi:10.1007/s00586-011-2099-5.
16. Nakhla M, Scuccimarri R, Duffy KN, et al. Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia. J Pediatr. 2009;154(3):438-43. doi:10.1016/j.jpeds.2008.09.023.
17. Markula-Patjas KP, Valta HL, Kerttula LI, et al. Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis. J Rheumatol. 2012;39(2):365-73. doi:10.3899/jrheum.110305.
18. Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-48. doi:10.1002/jbmr.5650080915.
19. Makitie O, Doria AS, Henriques F, Cole WG, Compeyrot S, Silverman E, et al. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr. 2005;146(3):395-401. doi:10.1016/j.jpeds.2004.10.052.
20. Regio P, Bonfa E, Takayama L, et al. The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus. 2008;17(9):787-92. doi:10.1177/0961203308089446.
21. Reyes ML, Hernandez MI, King A, et al. Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures. Clin Exp Rheumatol. 2007;25(2):329-35.
22. Valta H, Lahdenne P, Jalanko H, et al. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007;34(4):831-6.
23. Huber AM, Gaboury I, Cabral DA, et al. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res. 2010;62 (4):516-26. doi:10.1002/acr.20171.
24. Toiviainen-Salo S, Markula-Patjas K, Kerttula L, et al. The thoracic and lumbar spine in severe juvenile idiopathic arthritis: magnetic resonance imaging analysis in 50 children. J Pediatr. 2012;160(1):140-6. doi:10.1016/j.jpeds. 2011.06.030.
25. Lim LS, Benseler SM, Tyrrell PN, et al. Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients. Ann Rheum Dis. 2012. doi:10.1136/annrheumdis-2011-200805.
26. Kjaer P, Leboeuf-Yde C, Sorensen JS, et al. An epidemiologic study of MRI and low back pain in 13-year-old children. Spine. 2005;30(7):798-806.
27. Tertti MO, Salminen JJ, Paajanen HE, et al. Low-back pain and disk degeneration in children: a case-control MR imaging study. Radiology. 1991;180(2):503-7.
28. Salminen JJ, Erkintalo MO, Pentti J, et al. Recurrent low back pain and early disc degeneration in the young. Spine. 1999;24 (13):1316-21.
29. Rodd C, Lang B, Ramsay T, et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res. 2012;64(1):122-31. doi:10.1002/acr.20589
30. Fields AJ, Keaveny TM. Trabecular architecture and vertebral fragility in osteoporosis. Curr Osteoporos Rep. 2012;10(2):132-40 doi:10.1007/s11914-012- 0097-0.
31. Wetzsteon RJ, Shults J, Zemel BS, et al. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res. 2009;24 (3):503-13. doi:10.1359/jbmr. 081101.
32. Simonini G, Giani T, Stagi S, et al. Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis. Rheumatology (Oxford). 2005;44(6):777-80. doi:10.1093/rheumatology/keh592.
33. Siminoski K, Lee KC, Jen H, et al. Anatomical distribution of vertebral fractures: comparison of pediatric and adult spines. Osteoporos Int. 2012;23(7):1999-2008. doi:10.1007/s00198-011- 1837-1.
34. Lien G, Selvaag AM, Flato B, et al. A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis. Arthritis Rheum. 2005;52 (3):833-40. doi:10.1002/art.20963.
35. Kroger H, Kotaniemi A, Vainio P, et al. Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner. 1992;17(1):75-85.
36. Lin WC, Cheng TT, Lee YC, et al. New vertebral osteoporotic compression fractures after percutaneous vertebroplasty: retrospective analysis of risk factors. J Vasc Int Radiol: JVIR. 2008;19(2 Pt 1):225-31. doi:10.1016/j.jvir. 2007.09.008.
37. Pelajo CF, Lopez-Benitez JM, Miller LC. 25-hydroxyvitamin D levels and vitamin D deficiency in children with rheumatologic disorders and controls. J Rheumatol. 2011;38(9):2000-4. doi:10.3899/jrheum.110123.
38. Wright TB, Shults J, Leonard MB, et al. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr. 2009;155 (2):260-5. doi:10.1016/j.jpeds.2009.02.033.
39. Lovell DJ, Glass D, Ranz J, et al. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis Rheum. 2006;54(7):2235-42. doi:10.1002/art.21956.
40. Ross AC, Taylor CL, Yaktine AL, et al. Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine. The National Academies Press. 2011.
41. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. doi:10.1210/jc.2011- 0385.
42. Roux C, Fechtenbaum J, Kolta S, et al. Mild prevalent and incident vertebral fractures are risk factors for new fractures. Osteoporos Int. 2007;18(12):1617-24. doi:10.1007/s00198-007-0413-1.